Paramagnetic nitroxides have been proposed as probes in electron param
agnetic resonance (EPR) imaging and in clinical diagnosis. However, ni
troxides are rapidly reduced in vivo to hydroxylamines, diamagnetic EP
R-inactive species. Reduction occurs in blood via soluble agents such
as ascorbic acid, as well as in the cells via enzymatic and non-enzyma
tic endocellular systems. To prevent the reduction, a water soluble ni
troxide, i.e., potassium peroxylamine disulfonate, is entrapped in rev
erse phase evaporation vesicles. The loaded liposomes have a high entr
apment capacity, and vesicles with the encapsulated agent are stable f
or days, even at room temperature. The vesicles in vitro can almost co
mpletely prevent the reduction of the entrapped nitroxide by ascorbic
acid. In blood of a rat, enriched with a homogenate of rat liver prote
ins, the vesicles are able to greatly prolong the life time of the nit
roxide. In particular, the encapsulated nitroxide has a half-life of m
ore than one hour, compared to two minutes for free nitroxide under th
e same conditions. Due to these protective effects, the lipid vesicles
might be useful as a delivery system for paramagnetic agents.